4Baptista A M,Belfort P. Comparison of methotrexate,actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia[J]. Int J Gynaecol Obstet,2012,119( 1 ) :35-38.
5Alifrangis C, Agarwal R, Short D, et al. EMMCO for high-risk gestation- al trophoblastic neoplasia:good outcomes with induction low-dose etopo- side-cisplatin and genetic analysis[J].J Clin Oncol, 2013,31 ( 2 ) : 280-286.
6Turan T,Karacay O, Tulunay G , et al. Results with EMA/CO ( E- toposide, Methotrexate, Actinomycin D , Cyclop hosphamide, Vin- cristine) Chemotherapy in Gestational Trophoblastic Neoplasia [J].Int J Gynecol Cancer, 2006, 16(3) : 1432-1438.
7Kim S J,Bae S N, Kim J H, et al. Effects of muhiagent chemotherapy and independent risk factors in the treatment of high risk GTF- 25 years experiences of KRI-TRD[J] .IntJ Gynaecol Obstet, 1998,60( 11 ) : 85-96.
8Rustin G J,Newlands E S, Lutz J M,et al.Combination but not Single-a- gent Methotrexate Chemotherapy for Gestational Trophoblastic Tumors In- creases the Incidence of Second Tumors [J],l Clin Oncol, 1996,14 (10) : 2769-2777.
